Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Antibody Response after 3 Dose Booster against SARS-CoV-2 mRNA Vaccine in Kidney Transplant Recipients

Version 1 : Received: 29 July 2023 / Approved: 31 July 2023 / Online: 1 August 2023 (10:38:45 CEST)

A peer-reviewed article of this Preprint also exists.

Tripodi, D.; Dominici, R.; Sacco, D.; Santorelli, G.; Rivera, R.; Acquaviva, S.; Marchisio, M.; Brambilla, P.; Battini, G.; Leoni, V. Antibody Response after 3-Dose Booster against SARS-CoV-2 MRNA Vaccine in Kidney Transplant Recipients. Vaccines 2024, 12, 264, doi:10.3390/vaccines12030264. Tripodi, D.; Dominici, R.; Sacco, D.; Santorelli, G.; Rivera, R.; Acquaviva, S.; Marchisio, M.; Brambilla, P.; Battini, G.; Leoni, V. Antibody Response after 3-Dose Booster against SARS-CoV-2 MRNA Vaccine in Kidney Transplant Recipients. Vaccines 2024, 12, 264, doi:10.3390/vaccines12030264.

Abstract

The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with a high rate of mortality in kidney transplant recipients (KTRs). The current vaccine strategy for KTRs seems to be unable to provide effective protection against coronavirus disease 2019 (COVID-19) [2] and the occurrence of severe COVID-19 in some vaccinated KTRs suggested a lack of immunity. We analized here the antibody response in a group of 32 kidney transplant recipients (KTR) followed at the Nephrology and Dialysis unit of the Hospital Pio XI of Desio, Italy, compared with a group of 23 healthy workers classified as Late responders (HCW-LR) (10 males age 27-62) and 13 females (age 46-64). We observed that the patients need additional vaccine boosters due to their immunocompromised status and therapy to protect them from infections related to viral variants, in accordance with the literature.

Keywords

Covid-19; antibody response; vaccination; kidney transplant recipients

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.